Exploration of the diagnostic utility of next generation sequencing with TruSight cancer panel for BRCA negative hereditary breast and ovarian cancer patients

被引：0
|
作者：
Dacheva, D.
Dodova, R.
Mitkova, A.
Kamenarova, K.
Tzveova, R.
Popov, I.
Vlahova, A.
Taushanova-Hadjieva, M.
Valev, S.
Dikov, T.
Timcheva, K.
Christova, S.
Mitev, V.
Kaneva, R.
机构：
[1] Med Univ Sofia, Fac Med, Mol Med Ctr, Sofia, Bulgaria
[2] Med Univ Sofia, Univ Hosp Alexandrovska, Gen & Clin Pathol Clin, Sofia, Bulgaria
[3] Nadezhda Womens Hlth Hosp, Clin Med Oncol Chemotherapy, Sofia, Bulgaria
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P2-09-18
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-09-18
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Next-Generation Sequencing as a Diagnostic Tool for Hereditary Breast and Ovarian Cancer
    Dai, Z.
    Bean, L. J.
    Collins, C.
    Askree, S. H.
    Alexander, J. J.
    Hegde, M.
    Tanner, A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 761 - 761
  • [2] Next generation sequencing for diagnosis of patients with hereditary breast and ovarian cancer
    Bhai, P.
    Gupta, D.
    Saxena, R.
    Verma, I. C.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S134 - S134
  • [3] Somatic mutation profiling in BRCA-negative breast and ovarian cancer patients by multigene panel sequencing
    Kwong, Ava
    Cheuk, Isabella W. Y.
    Shin, Vivian Yvonne
    Ho, Cecilia Y. S.
    Au, Chun-Hang
    Ho, Dona N. Y.
    Wong, Elaine Y. L.
    Yu, Stephanie W. Y.
    Chen, Jiawei
    Chan, Karen K. L.
    Ngan, Hextan Y. S.
    Chan, Tsun-Leung
    Ma, Edmond S. K.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (09): : 2919 - +
  • [4] Next-Generation Sequencing of the BRCA1 and BRCA2 Genes for the Genetic Diagnostics of Hereditary Breast and/or Ovarian Cancer
    Trujillano, Daniel
    Weiss, Maximilian E. R.
    Schneider, Juliane
    Koester, Julia
    Papachristos, Efstathios B.
    Saviouk, Viatcheslav
    Zakharkina, Tetyana
    Nahavandi, Nahid
    Kovacevic, Lejla
    Rolfs, Arndt
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (02): : 162 - 170
  • [5] Clinical Contribution of Next-Generation Sequencing Multigene Panel Testing for BRCA Negative High-Risk Patients With Breast Cancer
    Solmaz, Asli Ece
    Yeniay, Levent
    Gokmen, Erhan
    Zekioglu, Osman
    Haydaroglu, Ayfer
    Bilgen, Isil
    Ozkinay, Ferda
    Onay, Huseyin
    CLINICAL BREAST CANCER, 2021, 21 (06) : E647 - E653
  • [6] Four novel BRCA variants found in Chinese hereditary breast cancer patients by next-generation sequencing
    Liu, Peng-fei
    Zhuo, Zhong-ling
    Xie, Fei
    Wang, Shu
    Zhao, Xiao-tao
    CLINICA CHIMICA ACTA, 2021, 516 : 55 - 63
  • [7] Evaluation on the mutation screening by next-generation sequencing in hereditary breast and ovarian cancer: Implementation of recurrent mutation panel
    Kwong, A.
    Shin, V. Y.
    Au, C. H.
    Law, F. B.
    Ho, D. N.
    Ip, B. K.
    Wong, A. T.
    Lau, S. S.
    To, R. M.
    Choy, G.
    Ford, J. M.
    Ma, E. S.
    Chan, T. L.
    CANCER RESEARCH, 2016, 76
  • [8] Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing
    Tuncer, Seref Bugra
    Celik, Betul
    Erciyas, Seda Kilic
    Erdogan, Ozge Sukruoglu
    Gultaslar, Busra Kurt
    Odemis, Demet Akdeniz
    Avsar, Mukaddes
    Sen, Fatma
    Saip, Pinar Mualla
    Yazici, Hulya
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 254
  • [9] Next-Generation Gene Sequencing: Looking Beyond Hereditary Breast and Ovarian Cancer
    Estrada, Sylvia S.
    LeGrazie, Bridget
    McKamie, Tammy
    Montgomery, Susan
    ONCOLOGY NURSING FORUM, 2015, 42 (06) : 691 - 694
  • [10] Next-generation sequencing in BRCA1/2-negative breast and ovarian cancer families.
    Hauke, Jan
    Heimbach, Andre
    Richters, Lisa Katharina
    Kroeber, Sandra
    Altmuller, Janine
    Thiele, Holger
    Nuernberg, Peter
    Wappenschmidt, Barbara
    Neidhardt, Guido
    Rhiem, Kerstin
    Schmutzler, Rita K.
    Hahnen, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345